Refine your search

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A Phase 1/2, Open-label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects with Advanced or Metastatic Malignancies Harboring ALK, ROS1, or NTRK1-3 Alterations

Repotrectinib for cancer that has returned or is not responding to treatment
Suzanne Treadway at streadway@pennstatehelath.psu.edu or 717-531-3097
All
All
This study is NOT accepting healthy volunteers
NCT04094610
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
You have cancer that has returned or is not respondin g to treatment
You are positive for certain changes in your genes which we will test you for as needed
Exclusion Criteria:
1. You have gastrointestinal disease, such as Crohn’s disease,
Cancer
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA